Swiss company Nanoflex Robotics has deployed its robotics system to carry out neurovascular procedures at the Jacobs Institute in the US.
The first remote-ready system has been installed at the Jacobs Institute’s testing facility within the University at Buffalo’s Canon Stroke and Vascular Research Center.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Using a small magnetic field generator and a navigation control unit, it will guide highly flexible devices within the body for various intricate vascular interventions.
The system enables physicians to bend, control and guide the guidewire tip through the vasculature of the body, facilitating procedures at the bedside or remotely from distant locations.
Nanoflex Robotics CEO Matt Curran said: “We are thrilled to collaborate with the esteemed Jacobs Institute in New York for the first installation of our robotics system. We believe remote robotics has the potential to transform surgical outcomes and benefit patients by enabling greater and earlier access to critical treatments.”
The initial focus of the company is to realise remote mechanical thrombectomies for acute ischemic stroke patients.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe Nanoflex Robotics system reduces the requirement for inter-hospital transfers, thereby shortening the time to reperfusion.
A non-profit organisation, the Jacobs Institute will utilise the remote-ready robotics system for a range of activities including usability testing, in-vivo studies and physician training.
Jacobs Institute CEO and CMO Adnan Siddiqui said: “Robotic neurovascular intervention is undoubtedly the future. We are delighted to work with Nanoflex Robotics to prove this concept.”
Last year, Nanoflex Robotics secured $12m in financing to commercialise its first-generation robotic platform and accelerate the development of new neuro-interventional products.
